Tanvex BioPharma, Inc. announced the resignation of Dr. Yun Yen as CEO. Resume of the previous position holder: Tanvex Biopharma, Inc. Chairman/CEO. Effective date is December 29, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
42.35 TWD | +4.05% | +6.41% | -34.95% |
May. 28 | Tanvex BioPharma, Inc.(TWSE:6541) dropped from S&P Global BMI Index | CI |
May. 13 | Tanvex BioPharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
-34.95% | 215M | |
+18.03% | 125B | |
+13.91% | 108B | |
-7.06% | 23.64B | |
+2.56% | 22.39B | |
-11.74% | 17.78B | |
-41.74% | 16.43B | |
-14.61% | 16.34B | |
+0.72% | 13.56B | |
+25.45% | 11.59B |
- Stock Market
- Equities
- 6541 Stock
- News Tanvex BioPharma, Inc.
- Tanvex BioPharma, Inc. Announces Resignation of Yun Yen as CEO, Effective December 29, 2023